IT companies are entering fresh contracts for hedging at Rs 47.5 per dolllar now.

Thus, the next few quarter incomes are going to be very very high because of this and guaranteed to be atleast at Rs 47 per dollar....

The best part is IT companies are entering fresh contracts for hedging at Rs 47.5 per dolllar now.

Thus, the next few quarter incomes are going to be very very high because of this and guaranteed to be atleast at Rs 47 per dollar....

US dollar is at Rs 47.60 now...

Motilal Oswal has come out with its earning estimates on software sector for the quarter ended September 2008. According to the report, TCS revenues are expected to go up 8.3% at Rs 69,431 million versus Rs 64,107 million, QoQ.

The company`s net profit is seen up 13.4% at Rs 14,106 million versus Rs 12,436 million, QoQ.

...

Infy Sept qtr PAT seen up 10.5% at Rs 1439 cr.

Motilal Oswal has come out with its earning estimates on software sector for the quarter ended September 2008. According to the report, Infosys revenues are expected to go up 8.9% at Rs 52,844 million versus Rs 48,540 million, QoQ.

The company`s net profit is seen up 10.5% at Rs 14,390 million versus Rs 13,020 million, QoQ.


...

Hi, your finance basics and knowledge are totally fundamentally incorrect. You need to learn a lot....

IT companies are saying that they are strong about their guidance and the markets are reacting wrongly to business prospect for IT companies.

On one side people are scared that business is going to be dented because of the meltdown in the Wall Street but on the other hand rupee has depreciated so much.

Also, US always looks at India for cost savings and manpower for IT....

Bogus figures and bogus company. sundry debtors not recoverable from US business is not provided. Exchange losses not provided for. When US is collapsing, where in the world they could get so much profit. Auditors have been thrown bones, to keep quiet . BOgus accounting norms followed by the company.Those who invest on the bogus figures are going to see great pain in the days to come. I SUGGEST EXIT THIS STOCK AT THE EARLIEST...

IT companies are entering fresh contracts for hedging at Rs 47.5 per dolllar now. Thus, the next few quarter incomes are going to be very very high because of this and guaranteed to be atleast at Rs 47 per dollar....

US dollar is at Rs 47.60 now...

Eli Lilly and Company, a leading innovation-driven pharmaceutical corporation, has awarded TCS the 2008 Global Supplier Award for information technology excellence. The Supplier Award recognizes suppliers who demonstrate superior performance with winning behaviors key to Lilly’s success. ...

Well i don`t know whose fundamentals are incorrect but just go over my post carefully and let me know which para you think is wrong. Give your calulations to prove and i ll accept your words if you are right....

Good news. TCS close to buying Citi’s BPO arm for $ 550 million -ET...

Eli Lilly and Company, a leading innovation-driven pharmaceutical corporation, has awarded TCS the 2008 Global Supplier Award for information technology excellence. The Supplier Award recognizes suppliers who demonstrate superior performance with winning behaviors key to Lilly’s success. Awardees were chosen on the basis of measurable impact made by the supplier on Lilly`s corporate objectives and priorities through the delivery of exemplary quality, speed, service and/or cost reduction. Lilly Chief Executive Officer John Lechleiter noted TCS’ exemplary contribution as an elite supplier of IT services and solutions, during a recent ceremony at the company’s Indianapolis-based headquarters. Debashis Ghosh, TCS Vice President, Head Life Sciences and Healthcare, said “TCS helps clients experience certainty by delivering best in class and innovative solutions. The award is an acknowledgement of the hard work put in by our people and a culture of continuous improvement institutionalized within the team. We deeply appreciate Lilly’s recognition of our efforts.” TCS` Life Sciences business services cover the spectrum from drug discovery, clinical trials, clinical data management, statistical analysis, medical writing and drug development, to manufacturing, pharmaceutical sales & distribution and product management. In Healthcare, TCS` experience includes hospital management systems (HMS), electronic health record systems, supply chain management, HIPAA administrative simplification compliance, business intelligence and customer health portals. ...